Dynavax Technologies
DVAX
#5100
Rank
S$2.33 B
Marketcap
S$19.85
Share price
0.00%
Change (1 day)
9.26%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -S$48.58 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are S$0.33 Billion. In 2024 the company made an earning of S$48.2 Million, an increase over its 2023 earnings that were of S$3.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$48.58 Million-200.76%
2024 S$48.2 M1475.31%
2023 S$3.06 M-99.2%
2022 S$0.38 B238.78%
2021 S$0.11 B-257.89%
2020 -S$71.94 Million-58.58%
2019 -S$0.18 Billion-9.32%
2018 -S$0.2 Billion60.44%
2017 -S$0.12 Billion-15.8%
2016 -S$0.15 Billion4.22%
2015 -S$0.14 Billion16.54%
2014 -S$0.12 Billion37.09%
2013 -S$85.14 Million
2010 -S$60.94 Million214.85%
2009 -S$19.36 Million-37.33%
2008 -S$30.89 Million-66.07%
2007 -S$91.03 Million16.92%
2006 -S$77.86 Million170.36%
2005 -S$28.8 Million33.39%
2004 -S$21.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$8.84 B-20,481.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$13.17 B-30,455.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$1.29 B-3,084.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-S$2.51 Billion 5,669.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.84 B-22,792.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$18.35 B-42,392.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$10.10 B-23,381.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
S$0.19 B-545.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.05 B-4,836.19%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel